Company news: Cann Global; Elixinol; Bod Science; AusCann; IvyMed Clinic; Botanix by Steve Jones and Martin Lane April 5, 2023April 30, 2024 Cann Global has entered the seventh month of a trading halt as the company continues to […]
Strategic review continues at Elixinol as management mull sale or merger by Steve Jones May 4, 2022April 29, 2024
Elixinol Wellness boss steps down with sale or merger still on the cards by Martin Lane March 28, 2022April 29, 2024
All options on the table for Elixinol as losses narrow by 50% by Martin Lane February 28, 2022April 29, 2024
Company news: Cronos; ECS Botanics; Elixinol; Zelira; Medlab; Emyria; Creso; MGC Pharma; Botanix; Incannex by Martin Lane February 2, 2022April 29, 2024
Company news: Rua Bioscience; Elixinol; Emyria; Cann Global; Health House; New Zealand Natural Fibres by Martin Lane December 22, 2021April 29, 2024
Company news: Cann Group; Releaf Group; Elixinol Wellness; Cronos Australia; Auscann; Zelira; Emyria; Incannex by cannabiz team October 21, 2021April 29, 2024
Company news: TCann; ECS Botanics; Cannaponics; Releaf Group; Cannvalate; Elixinol; Creso Pharma; Incannex by Martin Lane August 19, 2021April 26, 2024
